Narayana Hrudayalaya
1,753.50
-23.60(-1.33%)
Market Cap₹35,834.70 Cr
PE Ratio45.61
Company Performance:
1D-1.33%
1M+0.56%
6M-1.45%
1Y+37.37%
5Y+386.07%
View Company Insightsright
More news about Narayana Hrudayalaya
08Oct 25
Narayana Hrudayalaya Expands Global Footprint with New UK Subsidiary
Narayana Hrudayalaya's subsidiary, Health City Cayman Islands Ltd. (HCCI), has incorporated Narayana Hrudayalaya UK Ltd. in the United Kingdom. The new entity, registered on October 8, 2025, is a wholly-owned step-down overseas subsidiary with a paid-up share capital of GBP 1,000.00. This strategic move positions the company for potential investments outside the Cayman Islands and possible expansion into European markets.
11Aug 25
Narayana Hrudayalaya Reports Mixed Q1 Results, Expands Operations and Insurance Business
Narayana Hrudayalaya's Q1 results show improved India operations with expanded EBITDA margins, driven by better payor mix and higher-value procedures. Cayman Islands operations generated $45 million in revenue but faced EBITDA decline. The company announced expansion plans with INR 3,000 crores capex, mostly financed through borrowings. Digital transformation efforts are underway with 85% of patient documents digitalized. Oncology operations are growing, targeting 20-25% of total revenue within five years. The company's insurance business is showing promising growth with plans for expansion.
03Aug 25
Narayana Hrudayalaya Reports 15.4% Revenue Growth in Q1 FY26, Expands Healthcare Footprint
Narayana Hrudayalaya Limited reported robust financial results for Q1 FY26, with consolidated operating revenues reaching ₹15,073.00 million, a 15.4% year-over-year increase. The company achieved a consolidated EBITDA of ₹3,607.00 million with a 23.9% margin and a profit after tax of ₹1,961.00 million. The healthcare provider's network includes 40 facilities across India and the Cayman Islands, with 5,563 operational beds. Expansion plans target over 7,600 bed capacity with projects in Bangalore, Kolkata, and Raipur. The company also highlighted its digital transformation efforts and ESG initiatives, including mobile apps for patient care and a vision for sustainable healthcare.
01Aug 25
Narayana Hrudayalaya Reports Strong Q1 FY26 Results with 15.4% Revenue Growth
Narayana Hrudayalaya announced robust Q1 FY26 results with consolidated revenue reaching ₹15,073.00 million, a 15.4% year-on-year increase. EBITDA grew by 10.7% to ₹3,607.00 million. India operations revenue rose by 7.8%, while the Cayman Islands facility saw a 48.4% surge. The company reported its highest-ever quarterly revenue, with profit margins remaining high. Strategic developments include expanding facilities and introducing new medical procedures across various hospitals. The company maintains a positive outlook, focusing on growth in the Cayman Islands and Integrated Care business.
01Aug 25
Narayana Hrudayalaya Reports Mixed Q1 Results with Revenue Growth and Profit Decline
Narayana Hrudayalaya Limited announced Q1 results with consolidated operating revenue of ₹15,073.00 million, up 15.4% year-on-year. Profit After Tax (PAT) slightly decreased by 2.3% to ₹1,961.00 million. EBITDA grew 10.7% to ₹3,607.00 million. India operations revenue increased by 7.8%, while Cayman Islands facility saw 48.4% growth. The company expanded services across facilities and maintained a strong financial position with a net debt to equity ratio of 0.09.
28Jul 25
Narayana Hrudayalaya to Review Q1 Results and Debt Fundraising Proposal in Upcoming Board Meeting
Narayana Hrudayalaya Limited has announced a board meeting for August 1, 2025, to review Q1 financial results and consider a revised proposal for raising funds through debt securities via private placement. The debt fundraising proposal will require shareholder approval at the AGM scheduled for August 29, 2025. The company has informed stock exchanges in compliance with SEBI regulations.
24Jun 25
Narayana Hrudayalaya Secures BSE Nod for Merger Plan
Narayana Hrudayalaya, a leading healthcare provider, has received a no-objection from the Bombay Stock Exchange (BSE) for its proposed merger plan. This approval allows the company to proceed with subsequent stages of the merger process. While specific details of the merger remain undisclosed, this development is a crucial step in the company's strategic expansion plans.
11Jun 25
Narayana Hrudayalaya Injects $1 Million into Cayman Subsidiary for Working Capital
Narayana Hrudayalaya has invested $1 million (₹8.30 crore) into its downstream subsidiary, Cayman Integrated Healthcare, to support working capital requirements. This strategic move aims to bolster the company's international operations, particularly in the Caribbean region. The investment demonstrates Narayana Hrudayalaya's commitment to expanding its global footprint and ensuring operational efficiency in its overseas ventures.
23May 25
Narayana Hrudayalaya Reports Robust Q4 Results with 15% Revenue Growth and Announces Dividend
Narayana Hrudayalaya announced strong Q4 results with revenue increasing 14.84% to ₹1,470.00 crore and net profit rising to ₹197.00 crore. The company's EBITDA grew by 22.61% to ₹385.00 crore, with EBITDA margin improving to 26.07%. For the full fiscal year, revenue reached ₹5,093.40 crore, up 10.96%, while net profit surged 30.17% to ₹789.60 crore. The company recommended a dividend of ₹4.50 per equity share.
16May 25
Narayana Hrudayalaya to Consider Debt Securities Issuance in Upcoming Board Meeting
Narayana Hrudayalaya's board of directors will meet on May 23 to discuss potential fundraising through debt securities issuance. The company has not disclosed the targeted amount or intended use of funds. This move could impact the company's capital structure, support growth initiatives, and provide financial flexibility. The market's response to this announcement will be closely watched.
08Mar 25
Narayana Hrudayalaya's Subsidiary Forges Strategic Joint Venture to Revolutionize Cancer Care in India
Narayana Hrudayalaya's subsidiary, Health City Cayman Islands Ltd., has formed a joint venture with 2070 Health Inc. and W Health Ventures GP LLC to establish a network of cancer care centers in India. The venture, operating through Everhope Oncology Private Limited, will focus on chemotherapy services. HCCI will hold a 50% stake in the venture, with a total investment of USD 10 million planned over the next 1-2 years. This strategic move aims to enhance access to cancer treatment across India and strengthen Narayana Hrudayalaya's position in the oncology market.
21Feb 25
Narayana Hrudayalaya Breaks Ground on Massive ₹900 Crore Hospital Project in Kolkata
Narayana Hrudayalaya has initiated the construction of a 1,100-bed super-specialty hospital, 'Narayana Health City,' in New Town, Kolkata. The project, with an initial investment of ₹900 crore, will be developed in phases over 3-10 years. The first phase, a 350-bed facility, is expected to open in FY 2028-29. The expansion aims to meet the growing demand for quality healthcare in Eastern India, leveraging high patient footfall in existing Kolkata facilities. The foundation stone was laid in a ceremony attended by West Bengal Chief Minister Mamata Banerjee.
20Feb 25
Narayana Hrudayalaya Lays Foundation for Massive 1,100-Bed 'Health City' in Kolkata
Narayana Hrudayalaya has initiated a major expansion in Eastern India with the foundation stone laying of 'Narayana Health City' in Kolkata. The 1,100-bed super-specialty hospital project will be developed in phases over 3-10 years, with an initial investment of ₹900 crore for a 350-bed facility. The first phase is expected to be operational by FY 2028-29. The expansion is driven by high patient demand and aims to provide affordable, quality healthcare to West Bengal and Eastern India. The project will be financed through a combination of debt and internal accruals.
19Feb 25
Narayana Hrudayalaya Confirms Q3 FY25 Results, Expansion Plans, and Issues Rs. 500 Crore NCDs
Narayana Hrudayalaya confirmed a 2.6% increase in Q3 FY25 net profit to Rs. 192.9 crores. The company plans to expand its oncology services. It has approved the allotment of 50,000 NCDs worth Rs. 500 crores at 8.40% coupon rate, maturing on February 15, 2030. The audio recording of Q3 FY25 Earnings Call is now available on the company's website.
Narayana Hrudayalaya
1,753.50
-23.60
(-1.33%)
1 Year Returns:+37.37%
Industry Peers
Max Healthcare Institute
1,103.10
(+0.46%)
Apollo Hospitals
7,420.50
(-0.27%)
Fortis Healthcare
937.70
(-1.61%)
Narayana Hrudayalaya
1,753.50
(-1.33%)
Aster DM Healthcare
678.10
(+0.74%)
Global Health
1,174.90
(-2.24%)